Prostate Cancer
News
Finasteride May Prevent Prostate Cancer Without Increased Risk of Aggressive Cancers
(06/26/2008)
Treatment with finasteride for seven years reduced the incidence of prostate cancer by approximately 25% without increasing the incidence of aggressive prostate cancers. These findings, which included a reanalysis of previously reported results, were published in Cancer Prevention Research.
Bone Marker Associated with Survival in Breast, Prostate, and Lung Cancers
(06/23/2008)
The bone marker N-telopeptide of type I collagen (NTX) is associated with skeletal-related events and survival among patients with cancer that has spread to the bone (bone metastases). Improved outcomes may be achieved by reducing these markers through treatment with agents such as Zometa® (zoledronic acid). These results were recently published in the journal Cancer.
Salvage Radiotherapy Improves Prostate Cancer-specific Survival
(06/24/2008)
Radiation therapy following a recurrence of prostate cancer may reduce deaths specifically caused by the disease. These results were recently published in the Journal of the American Medical Association.
Fareston® Decreases Spinal Fractures in Men with Prostate Cancer
(06/10/2008)
Among prostate cancer patients receiving androgen deprivation therapy (ADT), treatment with Fareston® (toremifene citrate) reduces the risk of new spinal fractures. These results were presented at the 2008 annual meeting of the American Association for Cancer Research.
Updates in the Management of Prostate and Kidney Cancers
(05/07/2008)
A report from the 2008 ASCO Genitourinary Cancers Symposium
More
Prostate Cancer
Cancer News...